Sonendo, Inc. (SONX) stock

SONXOTCDental Equipment & SuppliesFiscal year ends December 31

Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Mar 26, 2025

$1.28+0.00 (0.00%)

Close on Oct 19, 2026Market cap $606.54KP/E –Yield –

Sonendo price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Sonendo's price to sales ratio was 0.0× on Oct 19, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 3.8×, with a median of 0.2×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	0.0×	+0.0
2025	Dec 31, 2025	0.0×	−0.0
2024	Dec 31, 2024	0.0×	−0.3
2023	Dec 29, 2023	0.3×	−3.3
2022	Dec 30, 2022	3.6×	+3.4
2021	Dec 31, 2021	0.2×	–

Where these numbers come from

Parsed from the XBRL in Sonendo's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-200 reverse split on Nov 8, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SONX.

Compare: SONX vs SNWV · SONX vs PROF · SONX vs VVOS · SONX vs IRIX · SONX vs QTI

Revenue growth-4.1% · median 45.2%

Gross margin35.7% · median 61.9%

Operating margin-88.5% · median -24.9%

Net margin-84.4% · median -54.6%

Company	Revenue	Growth
IRIX	$51.57M	+3.7%
SNWV	$41.33M	+0.8%
SONX	$33.20M	-4.1%
QTI	$29.58M	+157.3%
PROF	$23.63M	+65.3%
VVOS	$20.90M	+45.2%

Company

Exchange: OTC
Industry: Dental Equipment & Supplies
Fiscal year ends: December 31
Employees: 131
Auditor: Ernst & Young LLP
SEC CIK: 1407973

Advertisement
300 × 250

See a number that looks wrong?